A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB

<p>Abstract</p> <p>Background</p> <p>Although tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising agent for human cancer therapy, prostate cancer still remains resistant to TRAIL. Both X-linked inhibitor of apoptosis (XIAP) and nuclear factor-...

Full description

Bibliographic Details
Main Authors: Li Yongming, Tang Wenhua, Liu Meilan, Dai Yao, Lian Jiqin, Lawrence Theodore S, Xu Liang
Format: Article
Language:English
Published: BMC 2009-11-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/9/392
_version_ 1818514561891827712
author Li Yongming
Tang Wenhua
Liu Meilan
Dai Yao
Lian Jiqin
Lawrence Theodore S
Xu Liang
author_facet Li Yongming
Tang Wenhua
Liu Meilan
Dai Yao
Lian Jiqin
Lawrence Theodore S
Xu Liang
author_sort Li Yongming
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Although tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising agent for human cancer therapy, prostate cancer still remains resistant to TRAIL. Both X-linked inhibitor of apoptosis (XIAP) and nuclear factor-kappaB function as key negative regulators of TRAIL signaling. In this study, we evaluated the effect of SH122, a small molecule mimetic of the second mitochondria-derived activator of caspases (Smac), on TRAIL-induced apoptosis in prostate cancer cells.</p> <p>Methods</p> <p>The potential of Smac-mimetics to bind XIAP or cIAP-1 was examined by pull-down assay. Cytotoxicity of TRAIL and/or Smac-mimetics was determined by a standard cell growth assay. Silencing of XIAP or cIAP-1 was achieved by transient transfection of short hairpin RNA. Apoptosis was detected by Annexin V-PI staining followed by flow cytometry and by Western Blot analysis of caspases, PARP and Bid. NF-kappaB activation was determined by subcellular fractionation, real time RT-PCR and reporter assay.</p> <p>Results</p> <p>SH122, but not its inactive analog, binds to XIAP and cIAP-1. SH122 significantly sensitized prostate cancer cells to TRAIL-mediated cell death. Moreover, SH122 enhanced TRAIL-induced apoptosis via both the death receptor and the mitochondrial pathway. Knockdown of both XIAP and cIAP-1 sensitized cellular response to TRAIL. XIAP-knockdown attenuated sensitivity of SH122 to TRAIL-induced cytotoxicity, confirming that XIAP is an important target for IAP-inhibitor-mediated TRAIL sensitization. SH122 also suppressed TRAIL-induced NF-kappaB activation by preventing cytosolic IkappaB-alpha degradation and RelA nuclear translocation, as well as by suppressing NF-kappaB target gene expression.</p> <p>Conclusion</p> <p>These results demonstrate that SH122 sensitizes human prostate cancer cells to TRAIL-induced apoptosis by mimicking Smac and blocking both IAPs and NF-kappaB. Modulating IAPs may represent a promising approach to overcoming TRAIL-resistance in human prostate cancer with constitutively active NF-kappaB signaling.</p>
first_indexed 2024-12-11T00:17:29Z
format Article
id doaj.art-f175bf092fe44b528a9b921b6b48a6e1
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-11T00:17:29Z
publishDate 2009-11-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-f175bf092fe44b528a9b921b6b48a6e12022-12-22T01:27:53ZengBMCBMC Cancer1471-24072009-11-019139210.1186/1471-2407-9-392A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaBLi YongmingTang WenhuaLiu MeilanDai YaoLian JiqinLawrence Theodore SXu Liang<p>Abstract</p> <p>Background</p> <p>Although tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising agent for human cancer therapy, prostate cancer still remains resistant to TRAIL. Both X-linked inhibitor of apoptosis (XIAP) and nuclear factor-kappaB function as key negative regulators of TRAIL signaling. In this study, we evaluated the effect of SH122, a small molecule mimetic of the second mitochondria-derived activator of caspases (Smac), on TRAIL-induced apoptosis in prostate cancer cells.</p> <p>Methods</p> <p>The potential of Smac-mimetics to bind XIAP or cIAP-1 was examined by pull-down assay. Cytotoxicity of TRAIL and/or Smac-mimetics was determined by a standard cell growth assay. Silencing of XIAP or cIAP-1 was achieved by transient transfection of short hairpin RNA. Apoptosis was detected by Annexin V-PI staining followed by flow cytometry and by Western Blot analysis of caspases, PARP and Bid. NF-kappaB activation was determined by subcellular fractionation, real time RT-PCR and reporter assay.</p> <p>Results</p> <p>SH122, but not its inactive analog, binds to XIAP and cIAP-1. SH122 significantly sensitized prostate cancer cells to TRAIL-mediated cell death. Moreover, SH122 enhanced TRAIL-induced apoptosis via both the death receptor and the mitochondrial pathway. Knockdown of both XIAP and cIAP-1 sensitized cellular response to TRAIL. XIAP-knockdown attenuated sensitivity of SH122 to TRAIL-induced cytotoxicity, confirming that XIAP is an important target for IAP-inhibitor-mediated TRAIL sensitization. SH122 also suppressed TRAIL-induced NF-kappaB activation by preventing cytosolic IkappaB-alpha degradation and RelA nuclear translocation, as well as by suppressing NF-kappaB target gene expression.</p> <p>Conclusion</p> <p>These results demonstrate that SH122 sensitizes human prostate cancer cells to TRAIL-induced apoptosis by mimicking Smac and blocking both IAPs and NF-kappaB. Modulating IAPs may represent a promising approach to overcoming TRAIL-resistance in human prostate cancer with constitutively active NF-kappaB signaling.</p>http://www.biomedcentral.com/1471-2407/9/392
spellingShingle Li Yongming
Tang Wenhua
Liu Meilan
Dai Yao
Lian Jiqin
Lawrence Theodore S
Xu Liang
A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB
BMC Cancer
title A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB
title_full A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB
title_fullStr A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB
title_full_unstemmed A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB
title_short A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB
title_sort smac mimetic sensitizes prostate cancer cells to trail induced apoptosis via modulating both iaps and nf kappab
url http://www.biomedcentral.com/1471-2407/9/392
work_keys_str_mv AT liyongming asmacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab
AT tangwenhua asmacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab
AT liumeilan asmacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab
AT daiyao asmacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab
AT lianjiqin asmacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab
AT lawrencetheodores asmacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab
AT xuliang asmacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab
AT liyongming smacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab
AT tangwenhua smacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab
AT liumeilan smacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab
AT daiyao smacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab
AT lianjiqin smacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab
AT lawrencetheodores smacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab
AT xuliang smacmimeticsensitizesprostatecancercellstotrailinducedapoptosisviamodulatingbothiapsandnfkappab